EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficient suppression of premature termination codons with alanine by engineered chimeric pyrrolysine tRNAs

Aya Awawdeh, Alejandro Tapia, Sarah A Alshawi, Olabode Dawodu, Sarah A Gaier, Caitlin Specht, Jean-Denis Beaudoin, Jeffery M Tharp, Oscar Vargas-Rodriguez iD

Nucleic Acids Research · 11.12.2024 · 52 (22) · 14244-14259

DOI: 10.1093/nar/gkae1048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.11.2024. Verfasst von Aya Awawdeh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT 06030, USA. Hauptthemen laut MEDLINE: RNA, Transfer, Lysine, Codon, Nonsense, Alanine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Indiana Clinical and Translational Sciences Institute, NIGMS NIH HHS, Indiana University Precision Health Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations that introduce premature termination codons (PTCs) within protein-coding genes are associated with incurable and severe genetic diseases. Many PTC-associated disorders are life-threatening and have no approved medical treatment options. Suppressor transfer RNAs (sup-tRNAs) with the capacity to translate PTCs represent a promising therapeutic strategy to treat these conditions; however, developing novel sup-tRNAs with high efficiency and specificity often requires extensive engineering and screening. Moreover, these efforts are not always successful at producing more efficient sup-tRNAs. Here we show that a pyrrolysine (Pyl) tRNA (tRNAPyl), which naturally translates the UAG stop codon, offers a favorable scaffold for developing sup-tRNAs that restore protein synthesis from PTC-containing genes. We created a series of rationally designed Pyl tRNAScaffold Suppressor-tRNAs (PASS-tRNAs) that are substrates of bacterial and human alanyl-tRNA synthetase. Using a PTC-containing fluorescent reporter gene, PASS-tRNAs restore protein synthesis to wild-type levels in bacterial cells. In human cells, PASS-tRNAs display robust and consistent PTC suppression in multiple reporter genes, including pathogenic mutations in the tumor suppressor gene BRCA1 associated with breast and ovarian cancer. Moreover, PTC suppression occurred with high codon specificity and no observed cellular dysregulation. Collectively, these results unveil a new class of sup-tRNAs with encouraging potential for tRNA-based therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, TransferLysineCodon, NonsenseAlanineHumansProtein BiosynthesisBRCA1 ProteinAlanine-tRNA LigaseHEK293 CellsCodon, TerminatorEscherichia coliFemaleGenetic Engineering

Substanzen

pyrrolysineRNA, TransferLysineCodon, NonsenseAlanineBRCA1 ProteinAlanine-tRNA LigaseCodon, TerminatorBRCA1 protein, human

Autor:innen und Institutionen

  • Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT 06030, USA.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202, USA.
  • Department of Microbiology and Immunology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202, USA.
  • Department of Genetics and Genome Sciences, Institute for Systems Genomics, University of Connecticut Health Center, 400 Farmington Avenue, Farmington, CT 06030, USA.
  • Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 64 Turner Street, London, E1 2AD, UK.

ORCID-Profile: Oscar Vargas-Rodriguez

Förderung

  • Indiana Clinical and Translational Sciences Institute
  • NIGMS NIH HHS
  • Indiana University Precision Health Initiative
  • NIH HHS
  • NCATS NIH HHS
  • IUSCCC Vera Bradley and Catherine Peachy Foundation Breast Cancer Breakthrough Award
  • NCI NIH HHS
  • School of Medicine, University of Connecticut

Zitieren

APA

Awawdeh, A., Tapia, A., Alshawi, S. A., Dawodu, O., Gaier, S. A., Specht, C., Beaudoin, J. D., Tharp, J. M., & Vargas-Rodriguez, O. (2024). Efficient suppression of premature termination codons with alanine by engineered chimeric pyrrolysine tRNAs. Nucleic Acids Research, 52(22), 14244-14259. https://doi.org/10.1093/nar/gkae1048

Vancouver

Awawdeh A, Tapia A, Alshawi SA, Dawodu O, Gaier SA, Specht C, et al. Efficient suppression of premature termination codons with alanine by engineered chimeric pyrrolysine tRNAs. Nucleic Acids Research. 2024;52(22):14244-14259. doi:10.1093/nar/gkae1048

BibTeX
@article{Awawdeh2024,
  author = {Awawdeh, Aya and Tapia, Alejandro and Alshawi, Sarah A and Dawodu, Olabode and Gaier, Sarah A and Specht, Caitlin and Beaudoin, Jean-Denis and Tharp, Jeffery M and Vargas-Rodriguez, Oscar},
  title = {Efficient suppression of premature termination codons with alanine by engineered chimeric pyrrolysine tRNAs},
  journal = {Nucleic Acids Research},
  year = {2024},
  volume = {52},
  number = {22},
  pages = {14244--14259},
  doi = {10.1093/nar/gkae1048}
}
Kostenlos starten →